In this way, agents that are known to induce differentiation in keratinocytes (such as vitamin D3) may be shown to be more effective in Brk-positive breast cancer cells compared with Brk-negative cells, potentially identifying alternative therapy options. Here, PTK6 is linked to breast cancer.